SundaySeptember 06, 2015

• 11:15 - 12:45

  Symposium supported by Astellas

  Location: Colorado Convention Center, ,

  Chairs: Test, test, India

• 14:45 - 16:15

  Symposium supported by Bristol-Myers Squibb

  Location: Colorado Convention Center, ,

  Chairs: , ,

MondaySeptember 07, 2015

• 07:00 - 08:00

  Meet the Expert MTE 01: Endpoints in Clinical Trials in Advanced NSCLC (Ticketed Session)

  Location: Colorado Convention Center, ,

  Chairs: , ,

  • Endpoints in Clinical Trials in Advanced NSCLC - Tony Mok (Hong Kong)
  • Endpoints in Clinical Trials in Advanced NSCLC - Alice Shaw (USA)

• 07:00 - 08:00

  Meet the Expert MTE 02: Patients, Investigators and Pharmaceuticals Working Together to Accelerate Research and Access: The Lung Cancer Master Protocol (Lung-MAP) Clinical Trial (Ticketed Session)

  Location: Colorado Convention Center, ,

  Chairs: , ,

  • Patients,Investigators and Pharmaceuticals Working Together to Accelerate Research and Access: The Lung Cancer Master Protocol (Lung-MAP) Clinical Trial - Vassiliki Papadimitrakopoulou (USA)

• 07:00 - 08:00

  Meet the Expert MTE 03: Squamous Cell Lung Cancer (Ticketed Session)

  Location: Colorado Convention Center, ,

  Chairs: , ,

  • Squamous Cell Lung Cancer - Howard West (USA)

• 07:00 - 08:00

  Meet the Expert MTE 04: Molecular Testing in Community Settings (Ticketed Session)

  Location: Colorado Convention Center, ,

  Chairs: , ,

  • Molecular Testing in Community Settings - John Longshore (USA)

• 07:00 - 08:00

  Meet the Expert MTE 05: Chemotherapy for Localized NSCLC-Paradigms and Controversies (Ticketed Session)

  Location: Colorado Convention Center, ,

  Chairs: , ,

  • Chemotherapy for Localized NSCLC-Paradigms and controversies - Thierry Le Chevalier (France)

• 07:00 - 08:00

  Meet the Expert MTE 06: Survivorship After Combined Modality Therapy (Imaging, Salvage Therapy) (Ticketed Session)

  Location: Colorado Convention Center, ,

  Chairs: , ,

  • Survivorship After Combined Modality Therapy (Imaging, Salvage Therapy) - Yasuhi Nagata (Japan)
  • Survivorship After Combined Modality Therapy (Imaging, Salvage Therapy) - Joseph Salama (USA)

• 07:00 - 08:00

  Meet the Expert MTE 07: Pharmacologic and Non-Pharmacologic Management of Dyspnea (Ticketed Session)

  Location: Colorado Convention Center, ,

  Chairs: , ,

  • Pharmacologic and Non-Pharmacologic Management of Dyspnea - Alex Molasiotis (Hong Kong)

• 07:00 - 08:00

  Meet the Expert MTE 08: Tobacco Control: What Do the Experts Do? (Ticketed Session)

  Location: Colorado Convention Center, ,

  Chairs: , ,

  • Tobacco Control: What Do the Experts Do? - Emily Stone (Australia)

• 07:00 - 08:00

  Meet the Expert MTE 09: Treatment of Advanced SCLC including Second Line (Ticketed Session)

  Location: Colorado Convention Center, ,

  Chairs: , ,

  • Treatment of Advanced SCLC including Second Line - Taofeek Owonikoko (USA)
  • Treatment of Advanced SCLC including Second Line - Caicun Zhou (China)

• 07:00 - 08:00

  Meet the Expert MTE 10: Clinical Workup of CT Detected Nodules (Ticketed Session)

  Location: Colorado Convention Center, ,

  Chairs: , ,

  • Subsolid Nodules: What the Clinicians Need to Know - Kavita Garg (USA)
  • Clinical Workup of CT Detected Nodules - Reginald Munden (USA)

• 07:00 - 08:00

  Meet the Expert MTE 11: Mediastinal Tumors Including Thymic Tumors, Lymphoma, Germ-Cell Tumors: Biology, Diagnosis and Treatment (Ticketed Session)

  Location: Colorado Convention Center, ,

  Chairs: , ,

  • Mediastinal Tumors including Thymic Tumors, Lymphoma, Germ-Cell Tumors: Biology, Diagnosis and Treatment - Lawrence Einhorn (USA); Gregory Riely (USA); Enrico Ruffini (Italy)

• 08:15 - 09:45

  Plenary Plen 02: Lung Cancer Prevention and Screening

  Location: Colorado Convention Center, ,

  Chairs: Harvey Pass (USA), Carolyn Dresler (USA),

  • Lung Cancer Screening - Christine Berg (USA)
  • Epidemiology of Lung Cancer/Smoking in the World - TBA
  • International Tobacco Control: FCTC - TBA

• 09:45 - 10:45

  Networking Break and Poster Session 1

  Location: Colorado Convention Center, Exhibit Hall,

  Chairs: , ,

  Refreshments will be provided.

• 09:45 - 10:45

  Press Conference 2

  Location: Colorado Convention Center, ,

  Chairs: , ,

• 10:45 - 12:15

  Concurrent Abstract Sessions (Oral and Mini Oral)

  Location: Colorado Convention Center, various rooms,

  Chairs: , ,

• 12:30 - 14:00

  Industry Supported Symposium supported by Lilly Oncology

  Location: Colorado Convention Center, ,

  Chairs: , ,

• 14:15 - 15:45

  Mini Symposium MS 01: How to Treat Multiple GGO’s

  Location: Colorado Convention Center, ,

  Chairs: Jessica Donington (USA), Masahiro Tsuboi (Japan),

  • What is the Appropriate Diagnostic Technique in the Setting of Multiple GGO’s? - Charles Powell (USA)
  • What is the Role of Surgical Resection in the Setting of Multiple GGO’s? - Raja Flores (USA)
  • Is There a Role for Targeted Therapy or Conventional Chemotherapy in Patients with Multiple GGO’s? - Benjamin Levy, USA
  • The Pathologic Classification of GGO’s - Clinical Pathologic Correlation - Erik Thunnissen (Netherlands)

• 14:15 - 15:45

  Mini Symposium MS 02: Are Non-Tissue Biomarkers Ready for the Clinic?

  Location: Colorado Convention Center, ,

  Chairs: Andreas-Claudius Hoffmann (Germany), TBA,

  • Free Circulating Tumor DNA - Luk Joossens (Belgium)
  • Circulating Tumor Cells - Tilak Sundaresan (USA)
  • Proteomics of Serum or Plasma - Pierre Massion (USA)
  • Exhaled Breath - Nir Peled (Israel)

• 14:15 - 15:45

  Mini Symposium MS 03: Is Tumor Angiogenesis Still a Viable Target in Advanced NSCLC?

  Location: Colorado Convention Center, ,

  Chairs: Sanjay Popat (United Kingdom), Qinghua Zhou (China),

  • Current Understanding of the Biology - John Heymach (USA)
  • Current and Future Agents - Suresh Ramalingam (USA)
  • Where are we with Defining Potential Biomarkers - Geoffrey Liu (Canada)
  • An Update on Clinical Trials - Heather Wakelee (USA)

• 14:15 - 15:45

  Mini Symposium MS 04: Harnessing the Full Potential of the Immune System

  Location: Colorado Convention Center, ,

  Chairs: Charles Butts (Canada), Patrick Forde (USA),

  • PD1/PDL1 Studies - Roy Herbst (USA)
  • Other Immune Inhibitors - Naiyer Rizvi (USA)
  • Vaccines - Johan Vansteenkiste (Belgium)
  • Microenvironment as a Target - Steven Albelda (USA)

• 14:15 - 15:45

  Mini Symposium MS 05: Tumor Heterogeneity

  Location: Colorado Convention Center, ,

  Chairs: Sanja Dacic (USA), Andrew Nicholson (United Kingdom),

  • Oveview of Tumor Heterogeneity - Charles Swanton (United Kingdom)
  • How Does Tumor Heterogeneity Affect Molecular Testing on Biopsy Samples - Diagnostic vs. Rebiopsy (Resistance) - Keith Kerr (United Kingdom)
  • Genomic Evolution and Tumor Heterogeneity - David Sidransky (USA)
  • Hetergeneity and Drug Resistance - Solange Peters (Switzerland)

• 14:15 - 15:45

  Mini Symposium MS 06: Regulation of Tobacco Products

  Location: Colorado Convention Center, ,

  Chairs: Edgardo Santos (USA), Nise Yamaguchi (Brazil),

  • Global Effects of Smoking, of Quitting, and of Taxing Tobacco - TBA
  • The Framework Convention on Tobacco Control - TBA
  • FDA Regulation of Tobacco Products in the US - Mitch Zeller (USA)
  • The Role of Litigation in Controlling Tobacco Use - Richard Daynard (USA)

• 14:15 - 15:45

  Mini Symposium MS 07: SCLC Biology & Models

  Location: Colorado Convention Center, ,

  Chairs: Desmond Carney (Ireland), Philip Mack (USA),

  • PDX Models - Charles Rudin (USA)
  • GEMM Models (p53/Rb) - Kate Sutherland (Australia)
  • GEMM Models (Drug Development) - Julien Sage (USA)
  • GEMM Models Histopathology and ROCK Clutures - Adi Gazdar (USA)
  • Circulating Stem Cells - Fiona Blackhall (UK)

• 14:15 - 15:45

  Mini Symposium MS 08: BAP1 Cancer Syndrome and Mesothelioma

  Location: Colorado Convention Center, ,

  Chairs: Lee Krug (USA), Nico Van Zandwijk (Australia),

  • Mesothelioma and BAP1 Germline Mutations - Michele Carbone (USA)
  • BAP1 and Ubiquitination - El Bachir Affar (Canada)
  • Commonalities Between Meso and Uveal Melanomas - TBA
  • Skin Manifestations of the BAP1 Syndrome - TBA

• 14:15 - 15:45

  Mini Symposium MS 09a: The Palliative Care Multidisciplinary Team and Worldwide Perspective

  Location: Colorado Convention Center, ,

  Chairs: Roberto Ivan Lopez (Panama), Ana Oton (USA),

  • Nurse’s Perspective - Teresa Trabert (USA)
  • Doctor’s Perspective - TBA
  • Radiation Oncologist’s Perspective - Jeffrey Bradley (USA)
  • Patient and Caregiver’s Perspective - Regina Fink (USA)

• 14:15 - 15:45

  Mini Symposium MS 09b: Review of Limitations, Resources, Programs and Accomplishments of Supportive Care and Palliative Care Multidisciplinary Teams, by Continent

  Location: Colorado Convention Center, ,

  Chairs: Roberto Ivan Lopez (Panama), Ana Oton (USA),

  • Latin America - Eduardo Arnoldo Richardet (Argentina)
  • Africa - Moawia Elhassan (Sudan)
  • Asia/Oceania - Craig Underhill (Australia)
  • Europe - Jorn Herrstedt (Denmark)

• 14:15 - 15:45

  Mini Symposium MS 28: Management of Screening Detected Lung Cancer

  Location: Colorado Convention Center, ,

  Chairs: Peter Goldstraw (United Kingdom), Norihiko Ikeda (Japan), Bernard Park (USA), Luis Raez (USA)

  • Epidemiology of Lung Cancer and Smoking - Ping Yang (USA)
  • Risk Models - Martin Tammemagi (Canada)
  • What is the Ideal Method of Diagnosis for Screening Detected Lung Nodules? - Doug Minnich (USA)
  • When to Intervene on Screening Detected Lung Nodules - Giulia Veronesi (Italy)
  • Rationale for Sublobar Resection for Early Cancer - Hisao Asamura (Japan)
  • Is There a Role for SBRT in Screening Detected Non-Diagnosed Lung Nodules? - David Palma (Canada)
  • Biomarkers: Current Status and Future Direction - Rob Young (New Zealand)

• 14:15 - 15:45

  Pro Con PC 01a: Surgery vs. SBRT in Operable NSCLC

  Location: Colorado Convention Center, ,

  Chairs: David Harpole (USA), Pan-Chyr Yang (Taiwan),

  • SBRT - Suresh Senan (Netherlands)
  • Surgery - Paul Van Schil (Belgium)

• 14:15 - 15:45

  Pro Con PC 01b: Pro vs Con: SBRT for Non-Biopsied Lung Nodules

  Location: Colorado Convention Center, ,

  Chairs: Antoinette Wozniak (USA), TBA,

  • Pro - Kenneth Rosenzweig (USA)
  • Con - Robert Timmerman (USA)

• 14:15 - 15:45

  Education Session ED 01: Update in Radiation Oncology

  Location: Colorado Convention Center, ,

  Chairs: Walter Curran (USA), Paul van Houtte (Belgium),

  • Current Status of Proton and Heavy Particle Therapy - Hak Choy (USA)
  • Optimal Dose and Fractionation - James Urbanic (USA)
  • Post-Operative Radiotherapy for Stage III Disease - Francoise Mornex (France)
  • Radiation for Oligo-Progression - Benjamin Movsas (USA)

• 14:15 - 15:45

  Education Session ED 02: Molecular Testing around the World (Genomics in Clinic (Timelines/Bioinformatics), Testing Platforms & Algorithms (NGS, Targeted Panels, FISH, IHC), Cost Considerations, Strategies for Identifying Rare Genomic Subsets in Clinical Trials)

  Location: Colorado Convention Center, ,

  Chairs: Marc Ladanyi (USA), Gilberto Lopes (Brazil),

  • North America - Vincent Miller (USA)
  • Asia - Jin-Haeng Chung (South Korea)
  • Europe - Sylvie Lantuejoul (France)
  • Central/South America - Lilian (Mercedes) Dalurzo (Argentina)

• 14:15 - 15:45

  Education Session ED 03: Global Lung Cancer Coalition - Advocacy in Action

  Location: Colorado Convention Center, ,

  Chairs: Maureen Rigney (USA), Joan Schiller (USA),

  • Global Lung Cancer e-map - How Can This be Used as a Tool to Advocate for Change? - Sarah Winstone (United Kingdom)
  • Bibliometric Research on Published Lung Cancer Research - What are the Implications for Policy Work? - Richard Sullivan (United Kingdom)
  • The Value of National Lung Cancer Audit Data - The UK Experience - Jesme Fox (United Kingdom)
  • Advocating for Tobacco Control - The Australia experience - Matthew Peters (Australia)

• 14:15 - 15:45

  Education Session ED 04: How to Set up a Multidisciplinary Lung Cancer Program within a Community Care Environment and Provide Everyone with the Best Care for Lung Cancer

  Location: Colorado Convention Center, ,

  Chairs: Juan Manuel Luna (Guatemala), Samir Witta (USA),

  • How can Multi-Disciplinary Care be Executed at the Private Practice Level? - Eric Edell (USA)
  • How can we Strengthen MD Care in Large Hospital Systems? - Kathryn Mileham (USA)
  • Treating Diverse Communities - Laurie Carr (USA)
  • Differences in Rural/Urban Care - Craig Reynolds (USA)
  • The Utilization of Clinical Pathways to Guide Consistent Care in Lung Cancer - Edward Kim (USA)
  • Evaluating Quality of Care Outcomes from Screening to Treatment in Community Based Settings - Richard Booton (United Kingdom)

• 14:15 - 15:45

  Education Session ED 05: Case Presentations (3 Lung Cancer and 1 Mesothelioma) Discussed in Round Table Format

  Location: Colorado Convention Center, ,

  Chairs: Mary Duffy (Australia), Mary Hesdorffer (USA),

  • Nursing - Patricia Palmer (USA)
  • Respiratory Therapy - Larry Di Fabrizio (USA)
  • Social Work - Charla Peterson (USA)
  • Physician Assistant - Heather Grillo (USA)
  • PharmD - TBA
  • Nurse Practitioner - Michelle Turner (USA)

• 15:45 - 16:45

  Networking Break and Poster Session 1

  Location: Colorado Convention Center, Exhibit Hall,

  Chairs: , ,

  Refreshments will be provided.

• 16:45 - 18:15

  Concurrent Abstract Sessions (Oral and Mini Oral)

  Location: Colorado Convention Center, various rooms,

  Chairs: , ,

• 18:30 - 20:00

  Industry Supported Symposium supported by Clovis Oncology

  Location: Colorado Convention Center, ,

  Chairs: , ,

• 20:00 - 23:00

  Faculty Dinner (by invitation only)

  Location: , ,

  Chairs: , ,

TuesdaySeptember 08, 2015

• 07:00 - 08:00

  Concurrent Opposed Industry Supported Symposia

  Location: Colorado Convention Center, ,

  Chairs: , ,

• 07:00 - 08:00

  Highlights of the Previous Day HOD 01: Treatment of Advanced Disease

  Location: Colorado Convention Center, ,

  Chairs: , ,

  • Treatment of Advanced Disease - Yi-Long Wu (China)
  • Treatment of Localized Disease - Jessica Donington (USA)
  • Treatment of LocoRegional Disease - Chandra Belani (USA)
  • Small Cell/Thymoma/Mesothelioma/Other - Lee Krug (USA)

• 07:00 - 08:00

  Highlights of the Previous Day HOD 02: Biology, Pathology, Molecular Testing

  Location: Colorado Convention Center, ,

  Chairs: , ,

  • Biology, Pathology, Molecular Testing - Kenneth O'Byrne (Australia)
  • Prevention, Tobacco Control - Carolyn Dresler (USA)
  • Screening, Early Detection - Claudia Henschke (USA)

• 07:00 - 08:00

  Meet the Expert MTE 12: Therapy for Driver Mutation Positive Advanced NSCLC (Ticketed Session)

  Location: Colorado Convention Center, ,

  Chairs: , ,

  • Therapy for Driver Mutation Positive Advanced NSCLC - Federico Cappuzzo (Italy)

• 07:00 - 08:00

  Meet the Expert MTE 13: Standard of Care in Rare Thoracic Malignancies (Ticketed Session)

  Location: Colorado Convention Center, ,

  Chairs: , ,

  • Standard of Care in Rare Thoracic Malignancies - Nicolas Girard (France)

• 07:00 - 08:00

  Meet the Expert MTE 14: Proposal of Revised (8th) Edition of TNM Staging System for Lung Cancer (Ticketed Session)

  Location: Colorado Convention Center, ,

  Chairs: , ,

  • Proposal of Revised (8th) Edition of TNM Staging System for Lung Cancer - Mark Krasnik (Denmark)

• 07:00 - 08:00

  Meet the Expert MTE 15: Management of Major Airway and Vascular Obstruction (Ticketed Session)

  Location: Colorado Convention Center, ,

  Chairs: , ,

  • Management of Major Airway and Vascular Obstruction - Georgios Stamatis (Germany)

• 07:00 - 08:00

  Meet the Expert MTE 16: Living with Cancer and Sexuality (Ticketed Session)

  Location: Colorado Convention Center, ,

  Chairs: , ,

  • Living with Cancer and Sexuality - TBA

• 07:00 - 08:00

  Meet the Expert MTE 17: Dealing with Metastatic Bone Disease: Prevention of SRE, Managing Pain and Fractures (Ticketed Session)

  Location: Colorado Convention Center, ,

  Chairs: , ,

  • Dealing with Metastatic Bone Disease: Prevention of SRE, Managing Pain and Fractures - Vera Hirsh (Canada)

• 07:00 - 08:00

  Meet the Expert MTE 18: Chemoprevention Trials: Past, Present, and Future (Ticketed Session)

  Location: Colorado Convention Center, ,

  Chairs: , ,

  • Chemoprevention Trials: Past, Present, and Future - Dennis Wigle (USA)

• 07:00 - 08:00

  Meet the Expert MTE 19: Electronic Nicotine Delivery Devices (ENDS): eCigarettes (Ticketed Session)

  Location: Colorado Convention Center, ,

  Chairs: , ,

  • Electronic Nicotine Delivery Devices (ENDS): eCigarettes - Mike (Kenneth) Cummings (USA)

• 07:00 - 08:00

  Meet the Expert MTE 20: Biology and Pathology of Neuroendocrine Cancers (Ticketed Session)

  Location: Colorado Convention Center, ,

  Chairs: , ,

  • Biology and Pathology of Neuroendocrine Cancers - Keith Kerr (United Kingdom)

• 07:00 - 08:00

  Meet the Expert MTE 21: Early Detection of Central Airway Lesions: Biology and Practical Clinical Approaches (Ticketed Session)

  Location: Colorado Convention Center, ,

  Chairs: , ,

  • Early Detection of Central Airway Lesions: Biology and Practical Clinical Approaches - Annette McWilliams (Australia)
  • Early Detection of Central Airway Lesions: Biology and Practical Clinical Approaches - Gabriella Sozzi (Italy)

• 07:00 - 08:00

  Meet the Expert MTE 22: Diagnosis and Treatment of MPM: Overview (Ticketed Session)

  Location: Colorado Convention Center, ,

  Chairs: , ,

  • Diagnosis and Treatment of MPM: Overview - Arnauld Scherpereel (France)

• 08:15 - 09:45

  Plenary Plen 03: Lung Cancer: IASLC Global Initiatives

  Location: Colorado Convention Center, ,

  Chairs: Fred R. Hirsch (USA), Silvia Novello (Italy),

  • 2015 WHO Classification of the Pathology and Genetics of Tumors of the Lung - William Travis (USA)
  • Revised (8th) Edition of TNM Staging System for Lung Cancer - Ramon Rami-Porta (Spain)

• 09:45 - 10:45

  Networking Break and Poster Session 2

  Location: Colorado Convention Center, Exhibit Hall,

  Chairs: , ,

  Refreshments will be provided.

• 09:45 - 10:45

  Press Conference 3

  Location: Colorado Convention Center, Exhibit Hall,

  Chairs: , ,

• 10:45 - 12:15

  Concurrent Tue Morning Abstract Sessions (Oral and Mini Oral)

  Location: Colorado Convention Center, various rooms,

  Chairs: , ,

• 12:30 - 14:00

  Industry Supported Symposium supported by Merck

  Location: Colorado Convention Center, ,

  Chairs: , ,

• 14:15 - 15:45

  Pro Con PC 02a: Pro vs Con: Is There a Role for EGFR TKIs in EGFR Mutation Negative Disease?

  Location: Colorado Convention Center, ,

  Chairs: Sumitra Thongprasert (Thailand), Yi-Long Wu (China),

  • Pro - Scott Laurie (Canada)
  • Con - Lecia Sequist (USA)

• 14:15 - 15:45

  Pro Con PC 02b: Pro vs Con: Whole Exome Sequencing vs. Selected Testing (e.g., ALK and EGFR)

  Location: Colorado Convention Center, ,

  Chairs: Peter Meldgaard (Denmark), Kostas Syrigos (Greece),

  • Pro - Andrew Nicholson (United Kingdom)
  • Con - Yasushi Yatabe (Japan)

• 14:15 - 15:45

  Education Session ED 06: Treatment of Elderly and High Risk Patients with Localized NSCLC

  Location: Colorado Convention Center, ,

  Chairs: Cesare Gridelli (Italy), Peter Harper (United Kingdom),

  • Medical Oncology - Aminah Jatoi (USA)
  • Radiation Therapy - David Ball (Australia)
  • Surgery - Michael Weyant (USA)
  • Pulmonary - Gerard Silvestri (USA)

• 14:15 - 15:45

  Education Session ED 07: How to Treat Advanced Squamous Carcinoma of the Lung

  Location: Colorado Convention Center, ,

  Chairs: Byoung Chul Cho (South Korea), Fadlo Khuri (USA),

  • Overview of the Histology and Potential Driver Mutations - Peter Hammerman (USA)
  • Current State of the Art - Glenwood Goss (Canada)
  • Ongoing Trials Including Master Protocol etc. - David R. Gandara (USA)
  • Targeting Gene Amplification in Squamous Cancer - Paul Paik (USA)

• 14:15 - 15:45

  Education Session ED 08:Talking with Patients

  Location: Colorado Convention Center, ,

  Chairs: Luis Alberto Mas Lopez (Peru), Norma Pilnik (Argentina),

  • Transitioning to End of Life Care: Who Should Lead the Discussion? - TBA
  • The Art of Taking Care of Patients, The Art of Giving Bad News - TBA
  • Depression, The Silent Killer - Luis Ubillos (Uruguay)
  • Coping Mechanisms for Patients and Families - Natalie Doyle (United Kingdom)

• 14:15 - 15:45

  Education Session ED 09: Tissue is the Issue: Improving Diagnostic Yield in the Age of Minimally Invasive Procedures

  Location: Colorado Convention Center, ,

  Chairs: Philip Cagle (USA), TBA,

  • Optimal Biopsy, Challenges - Sanja Dacic (USA)
  • Difficulties Coordinating Care - Ray Osarogiagbon (USA)
  • What Do You Do With Tissue Once Collected? What Tests Are Useful? - Marileila Varella-Garcia (USA)
  • Prioritization of Tissue Use - Thomas Hensing (USA)

• 14:15 - 15:45

  Grand Rounds GR 01: Management of Challenging Clinical Scenarios in Localized lung Cancer

  Location: Colorado Convention Center, ,

  Chairs: John Mitchell (USA), TBA,

  • The Role of Localized Therapy in Lung Cancer Invading the Great Vessels - TBA
  • Should All Lung Tumors Invading the Chest Wall be Treated Like Pancoast Tumors? - Brendon Stiles (USA)
  • T4 Lung Tumors According to the New Classification - What is the Role of Surgery? - Daniel Boffa (USA)
  • Salvage Surgery After Chemoradiotherapy - Eric Vallieres (USA)

• 14:15 - 15:45

  Grand Rounds GR 02: Difficult Mesothelioma Cases

  Location: Colorado Convention Center, ,

  Chairs: Jaime de la Garza (Mexico), Andreas Rimner (USA), Anne Tsao (USA)

  • Case 1: A 70 Year Old with a Biphasic Stage I MPM - TBA
  • Case 2: A 65 Year Old with an Uncytoreduceable MPM - Paul Baas (Netherlands)
  • Case 3: A 65 Year Old with a Clinical Stage II MPM and Chest Pain - Joseph Friedberg (USA)
  • Addressing the Needs of the Mesothelioma Patient Who Has Exhausted Treatment Options: Palliation and Support for Family and Patient - Helen Clayson (United Kingdom); Liz Darlison (UK); Mary Hesdorffer (USA)

• 14:15 - 15:45

  Mini Symposium MS 10: New Approaches to Combined Modality Therapy for Stage III Disease

  Location: Colorado Convention Center, ,

  Chairs: David Jablons (USA), Jan van Meerbeeck (Belgium),

  • The Future of Radiation Therapy in Combined Modality Therapy - Rafal Dziadziuszko (Poland)
  • Future Role of Surgery (Timing, Patient Selection, and New Techniques) - Walter Weder (Switzerland)
  • New Systemic Approaches (Targeted Therapies and Immune Therapies) - Hossein Borghaei (USA)
  • Overview of Current International Randomized Trials - Simon Ekman (Sweden)

• 14:15 - 15:45

  Mini Symposium MS 11: NSCLC Stems Cells: Are They a Real Target?

  Location: Colorado Convention Center, ,

  Chairs: Caroline Dive (United Kingdom), Kazuhiko Nakagawa (Japan),

  • Biology of Cancer Stem Cells - Neil Watkins (Australia)
  • Current Therapeutic Targets and Ongoing Trials - Maximilian Diehn (USA)
  • Where To Go From Here? - Rafael Rosell (Spain)
  • Tumor-Propagating Cells in Non Small Cell Lung Cancers - Carla Kim (USA)

• 14:15 - 15:45

  Mini Symposium MS 12: The Other “–omics”

  Location: Colorado Convention Center, ,

  Chairs: Stephen Baylin (USA), Ite Laird-Offringa (USA),

  • Epigenomics - James Herman (USA)
  • Proteomics and Phosphoproteomics - Eric Haura (USA)
  • Genomics – Beyond the Driver Oncogene (Role of Tumor Suppressors, TP53, LKB1, PTEN, etc.) - Kwok-Kin Wong (USA)
  • Integrating “omics” for a Unified View of Lung Cancer - TBA

• 14:15 - 15:45

  Mini Symposium MS 13: Chemo Prevention Clinical Trials

  Location: Colorado Convention Center, ,

  Chairs: York Miller (USA), Pieter E. Postmus (Netherlands),

  • Preclinical Models: How Good Are They? - Robert Keith (USA)
  • Clinical Trials: Who Are the Proper Cohorts and How Do You Recruit Subjects? - Stephen Lam (Canada)
  • Pathologic Biomarkers of Risk and Benefit of Treatment - Dan Merrick (USA)
  • Chemoprevention Clinical Trials: How Do We Move Forward? How do we idenify valid end points? - Eva Szabo (USA)

• 14:15 - 15:45

  Mini Symposium MS 14: Current Screening Trials, Current Evidence and Screening Algorithms

  Location: Colorado Convention Center, ,

  Chairs: Peter Mazzone (USA), Tatiana Vidaurre-Rojas (Peru),

  • NLST, USPSTF Recommendations — Is Screening Going to Happen in USA? - James Mulshine (USA)
  • NELSON Emerging Data - Harry de Koning (Netherlands)
  • UKLS Impact of Utilization of Risk Assessment in Trial Selection - John Field (USA)
  • Screening in Japan- The JECS Study - Motoyasu Sagawa (Japan)

• 14:15 - 15:45

  Mini Symposium MS 15: Novel SCLC Therapies

  Location: Colorado Convention Center, ,

  Chairs: Carlos Barrios (Brazil), Nagahiro Saijo (Japan),

  • PARP Inhibitors and DNA Damage - Lauren Byers (USA)
  • Stem Cell/Notch/Hedghog - David Carbone (USA)
  • PI3K/AKT/mTOR - Shigeki Umemura (Japan)
  • Immunotherapy (Checkpoint Inhibitors) - Martin Reck (Germany)
  • Aurora Kinase and Cyclin Kinase Inhibitors - Clarissa Mathias (Brazil)
  • New Chemotherapies (Eribulin, Aldoxorubicin, Etrinotecan, MM398) - Ramaswamy Govindan (USA)

• 14:15 - 15:45

  Mini Symposium MS 16: Immunotherapy for Mesothelioma

  Location: Colorado Convention Center, ,

  Chairs: Dean Fennell (United Kingdom), Takashi Nakano (Japan),

  • Overview - Anna Nowak (Australia)
  • Immunotoxins and Mesothelin Antibody - Raffit Hassan (USA)
  • DC Vaccination - Joachim Aerts (Netherlands)
  • CTLA4 and PD-1 - Hedy Lee Kindler (USA)

• 14:15 - 15:45

  Mini Symposium MS 17: Advocacy Snapshots

  Location: Colorado Convention Center, ,

  Chairs: Patricia Mondragon (Mexico), Kim Norris (USA),

  • Tobacco Controls Impact on Lung Cancer - Glenda Colburn (Australia)
  • Advocates Making a Responsible Case for High-Risk Screening - Toshiyuki Sawa (Japan)
  • Developing a Framework for Excellence in Lung Cancer Screening – The Lung Cancer Alliance Experience - Laurie Fenton-Ambrose (USA)
  • Lung Cancer – A Health Issue for Women - Stefania Vallone (Italy)
  • Excellence in Treatment – Exporting Teaching Hospital Standards of Care to the Community Hospital Setting - Bonnie J Addario (USA)

• 14:15 - 15:45

  Mini Symposium MS 18: Global Nursing Issues in Lung Cancer

  Location: Colorado Convention Center, ,

  Chairs: Patricia Hollen (USA), Beth Ivimey (Australia),

  • Nursing Challenges in Clinical Trials - Christel Oyen (Belgium)
  • Screening for Distress, the 6th Vital Sign - TBA
  • Trends in Oncology Nursing in Japan - Keiko Iino (Japan)
  • The Importance of Pre- and Early Postoperative Rehabilitation in NSCLC Patient (Design and Rationale for the PROLUCA Study) - Malene Missel (Denmark)
  • Physicians and Nurse’s Expectations and Objectives Toward a Clinical Ethical Committee - TBA
  • Patient Time Burden Associated with Cancer Care - TBA

• 15:45 - 16:45

  Networking Break and Poster Session 2

  Location: Colorado Convention Center, Exhibit Hall,

  Chairs: , ,

  Refreshments will be provided.

• 16:45 - 18:15

  Concurrent Abstract Sessions (Oral and Mini Oral)

  Location: Colorado Convention Center, various rooms,

  Chairs: , ,

• 18:30 - 20:00

  Industry Supported Symposium supported by Boehringer Ingelheim

  Location: Colorado Convention Center, ,

  Chairs: , ,

• 20:00 - 23:00

  Gala Dinner (Ticketed Event)

  Location: Colorado Convention Center, ,

  Chairs: , ,

WednesdaySeptember 09, 2015

• 07:00 - 08:00

  Concurrent Opposed Industry Supported Symposia

  Location: Colorado Convention Center, ,

  Chairs: , ,

• 07:00 - 08:00

  Highlights of the Previous Day HOD 03

  Location: Colorado Convention Center, ,

  Chairs: , ,

  • Treatment of Advanced Disease - Luis Paz-Ares (Spain)
  • Treatment of Localized Disease - Mark Kris (USA)
  • Treatment of LocoRegional Disease - Ronald Natale (USA)
  • Small Cell/Thymoma/Mesothelioma/Other - Martin Edelman (USA)

• 07:00 - 08:00

  Highlights of the Previous Day HOD 04

  Location: Colorado Convention Center, ,

  Chairs: , ,

  • Small Cell/Thymoma/Mesothelioma/Other - Martin Edelman (USA)
  • Biology, Pathology, Molecular Testing - Philip Cagle (USA)
  • Prevention, Tobacco Control - Silvia Novello (Italy)
  • Screening, Early Detection - Pieter E. Postmus (Netherlands)

• 07:00 - 08:00

  Meet the Expert MTE 23: Standard Therapy for Advanced NSCLC in Absence of Driver Mutations (Ticketed Session)

  Location: Colorado Convention Center, ,

  Chairs: , ,

  • Standard Therapy for Advanced NSCLC in Absence of Driver Mutations - Corey Langer (USA)

• 07:00 - 08:00

  Meet the Expert MTE 24: Rising to the Challenge of Testing Small Biopsy Specimens (Ticketed Session)

  Location: Colorado Convention Center, ,

  Chairs: , ,

  • Rising to the Challenge of Testing Small Biopsy Specimens - Lynette Sholl (USA)

• 07:00 - 08:00

  Meet the Expert MTE 25: New Therapies for Squamous Cell Carcinoma (Ticketed Session)

  Location: Colorado Convention Center, ,

  Chairs: , ,

  • New Therapies for Squamous Cell Carcinoma - Shirish Gadgeel (USA)

• 07:00 - 08:00

  Meet the Expert MTE 26: Multidisciplinary Approach to a Comprehensive CT Screening Program (Ticketed Session)

  Location: Colorado Convention Center, ,

  Chairs: , ,

  • Multidisciplinary Approach to a Comprehensive CT Screening Program - David Midthun (USA)

• 07:00 - 08:00

  Meet the Expert MTE 27: Modern Approaches to Radiotherapy in Stage III Disease (Ticketed Session)

  Location: Colorado Convention Center, ,

  Chairs: , ,

  • Modern Approaches to Radiotherapy in Stage III Disease - Maria Werner-Wasik (USA)

• 07:00 - 08:00

  Meet the Expert MTE 28: Need for Team Building in Caring for Patients with Thoracic Malignancies (Ticketed Session)

  Location: Colorado Convention Center, ,

  Chairs: , ,

  • Need for Team Building in Caring for Patients with Thoracic Malignancies - Melissa Culligan (USA)
  • Need for Team Building in Caring for Patients with Thoracic Malignancies - Richard Gralla (USA)

• 07:00 - 08:00

  Meet the Expert MTE 29: Managing Side Effects from TKI (Ticketed Session)

  Location: Colorado Convention Center, ,

  Chairs: , ,

  • Managing Side Effects from TKI - Anne Fraser (New Zealand)

• 07:00 - 08:00

  Meet the Expert MTE 30: Cachexia (Ticketed Session)

  Location: Colorado Convention Center, ,

  Chairs: , ,

  • Cachexia - Amy Abernethy (USA)

• 07:00 - 08:00

  Meet the Expert MTE 31: Smoking Cessation Integrated with Screening (Window of Opportunity) (Ticketed Session)

  Location: Colorado Convention Center, ,

  Chairs: , ,

  • Smoking Cessation Integrated with Screening (Window of Opportunity) - Denise Aberle (USA)
  • Smoking Cessation Integrated with Screening (Window of Opportunity) - Jamie Ostroff (USA)

• 07:00 - 08:00

  Meet the Expert MTE 32: Treatment of Early Stage SCLC (Ticketed Session)

  Location: Colorado Convention Center, ,

  Chairs: , ,

  • Treatment of Early Stage SCLC - Jasek Jassem (Poland)
  • Treatment of Early Stage SCLC - Eric Lim (United Kingdom)

• 07:00 - 08:00

  Meet the Expert MTE 33: (Debate on) Prognostic Biomarkers in Mesothelioma (Ticketed Session)

  Location: Colorado Convention Center, ,

  Chairs: , ,

  • (Debate on) Prognostic Biomarkers in Mesothelioma - Raphael Bueno (USA)
  • (Debate on) Prognostic Biomarkers in Mesothelioma - Bruce Robinson (Australia)

• 08:15 - 09:45

  Plenary Plen 04: Science Drives Lung Cancer Advances

  Location: Colorado Convention Center, ,

  Chairs: Tetsuya Mitsudomi (Japan), Tony Mok (Hong Kong),

  • Lung Cancer Genomes - Adenocarcinoma - Matthew Meyerson (USA)
  • Lung Cancer Genomes - Squamous Cell Carcinoma/Small Cell - Roman Thomas (Germany)
  • Molecular Mechanisms of Drug Resistance - Pasi Janne (USA)
  • Personalized Medicine - Jean-Charles Soria (France)
  • Mouse Models of SCLC and NSCLC - Anton Berns (Netherlands)

• 09:45 - 10:45

  Press Conference 4

  Location: Colorado Convention Center, Exhibit Hall,

  Chairs: , ,

• 09:45 - 10:45

  Networking Break and Poster Session 3

  Location: Colorado Convention Center, Exhibit Hall,

  Chairs: , ,

  Refreshments will be provided.

• 10:45 - 12:15

  Concurrent Abstract Sessions (Oral and Mini Oral)

  Location: Colorado Convention Center, various rooms,

  Chairs: , ,

• 12:30 - 14:00

  Industry Supported Symposium supported by AstraZeneca

  Location: Colorado Convention Center, ,

  Chairs: , ,

• 14:15 - 15:45

  Mini Symposium MS 19: Joint Imaging/Therapy Conference

  Location: Colorado Convention Center, ,

  Chairs: Odd Terje Brustugun (Norway), Dominique Grunenwald (France),

  • Imaging for Surgical Treatment Decision and Planning - Hans Hoffmann (Germany)
  • Imaging for Radiation Therapy Planning - Jeffrey Bogart (USA)
  • Optimal Monitoring after Combined Modality Treatment (Imaging and Markers) - Michael MacManus (Australia)
  • Prevention, Diagnosis and Treatment of Radiation Pneumonitis - Laurie Gaspar (USA)

• 14:15 - 15:45

  Mini Symposium MS 20: Immunotherapy Predictive Biomarkers

  Location: Colorado Convention Center, ,

  Chairs: Kwun Fong (Australia), Thomas Lynch (USA),

  • Overview of Immunotherapy- Julie Brahmer (USA)
  • PD1/PDL1 Biomarker Strategies - Ignacio Wistuba (USA)
  • Assessment of immune Cells in Tumor Biopsies as a Biomarker - Elisabeth Brambilla (France)
  • Search for Genetic/Molecular Predictors of Immune Checkpoint Therapy - Role of KRAS, LKB1, Other Genetic Markers as Predictors for Immunotherapy - Scott Gettinger (USA)

• 14:15 - 15:45

  Mini Symposium MS 21: Variety in the Oncogene (Does the Exact Mutation Matter?)

  Location: Colorado Convention Center, ,

  Chairs: Robert Doebele (USA), Giorgio Scagliotti (Italy),

  • EGFR Mutations (e.g., Exon 18 vs. 19 vs. 20 vs. 21) - Daniel Costa (USA)
  • ALK, ROS1, and RET – Does the Partner Gene Matter? - Christine Lovly (USA)
  • MET - Gene Amplification vs. Overexpression vs. Exon 14 Skipping - Ravi Salgia (USA)
  • KRAS – Are All KRAS Mutations the Same? - Thomas Stinchcombe (USA)

• 14:15 - 15:45

  Mini Symposium MS 22: Risk Factors: Beyond the Cigarette

  Location: Colorado Convention Center, ,

  Chairs: Elisabeth Quoix (France), Nise Yamaguchi (Brazil),

  • Radon and Lung Cancer - TBA
  • Air Pollution-Outdoor; Biomass Smoke; Cooking Fuels - Paolo Boffetta (USA)
  • Legalization of Marijuana: Implication for Lung Health - James Jett (USA)
  • Other Tobacco Products Electronic Devices/Water Pipes/Hookas - Elizabeth Durmowicz (USA)
  • Cost Efficacy of Tobacco Cessation versus Treatment of Lung Cancer - William (Bill) Evans (USA)

• 14:15 - 15:45

  Mini Symposium MS 23: CT Screeening: Minimize Harm/Cost and Risk Assessment

  Location: Colorado Convention Center, ,

  Chairs: David Midthun (USA), Jesper Pedersen (Denmark),

  • Definition of Positive Cases and False Positives - David Yankelevitz (USA)
  • Software for Density Calculation and Timing of Surgery in Subsolid Nodules - Anthony Reeves (USA)
  • Role of PET Scan in Workup of Nodules - Ugo Pastorino (Italy)
  • Biomarkers in Selection for CT Screening /Management of Nodules - Harvey Pass (USA)

• 14:15 - 15:45

  Mini Symposium MS 24: Lung Carcinogenesis

  Location: Colorado Convention Center, ,

  Chairs: Wilbur Franklin (USA) , Harubumi Kato (Japan),

  • Early Airway Disease - Sam Janes (United Kingdom)
  • Premalignant Lesions: Genomics - Brigitte Gomperts (USA)
  • Peripheral Premalignancy - Ming Tsao (Canada)
  • Genomics of Alveolar Premalignancy - Masayuki Noguchi (Japan)
  • Premalignant Lesions: Cytokines and Microenvironment - Steven Dubinett (USA)

• 14:15 - 15:45

  Mini Symposium MS 25: Genomic Alterations and Drug Targets

  Location: Colorado Convention Center, ,

  Chairs: David Beer (USA), TBA,

  • Genomic Alterations - James Yang (Taiwan)
  • Myc, MAX, BRG1 - Montse Sanchez-Cespedes (Spain)
  • p53/Rb - John Minna (USA)
  • FGFR, MET, other TKIs - Lynn Heasley (USA)
  • Drug Screening Targets - TBA

• 14:15 - 15:45

  Mini Symposium MS 26: Advocacy in Practice

  Location: Colorado Convention Center, ,

  Chairs: Tommy Bjork (Sweden), Aoife McNamara (Ireland),

  • Influencing Clinical Trials to Meet Patients’ Needs and End-points – Involving the Patient from the Beginning - Gideon Blumenthal (USA)
  • Incorporating Quality of Life & Palliative Care Measures in Clinical Trial Designs - Raphael Catane (Israel)
  • Patient Advocate Groups Driving Progress – Using the Evidence - Craig Uthe (USA)
  • Setting up a Lung Cancer Patient Advocacy Group – Denmark’s Experience - Alice Skjold Braae (Denmark)
  • Supporting Lung Cancer Survivors – Living with and Beyond Lung Cancer - Janet Freeman-Daily (USA)

• 14:15 - 15:45

  Mini Symposium MS 27: Future Clinical Trials

  Location: Colorado Convention Center, ,

  Chairs: John Crowley (USA), Yu Shyr (USA),

  • Trial Designs - Mary Redman (USA)
  • Master Protocols - Shakun Malik (USA)
  • Biomarkers - Fred R. Hirsch (USA)
  • Future of Drug Approval - TBA

• 14:15 - 15:45

  Grand Rounds GR 03b: Treatment of Thymic Malignancies

  Location: Colorado Convention Center, ,

  Chairs: Paris Kosmidis (Greece), Enrico Ruffini (Italy),

  • Surgery - Frank Detterbeck (USA)
  • Radiotherapy - Daniel Gomez (USA)
  • Biology and Standard Treatment - Giuseppe Giaccone (USA)
  • Targeted Agents - Benjamin Besse (France)

• 14:15 - 15:45

  Grand Rounds GR 03a: Extensive Small Cell with Excellent Response to 1st Line Rx (PCI, Chest and/or Oligomet RT) and Second Line

  Location: Colorado Convention Center, ,

  Chairs: Bruce Johnson (USA), Brian Kavanagh (USA),

  • SCLC Therapy - Ritsuko Komaki (USA)
  • SCLC Therapy - Nevin Murray (Canada)

• 14:15 - 15:45

  Grand Rounds GR 04: Problems in Advanced Metastatic Disease

  Location: Colorado Convention Center, ,

  Chairs: Karen Kelly (USA), Robert Pirker (Austria),

  • Case of a Patient with EGFR Mutation Positive Disease and Two Small Brain Metastases - TBA
  • Leptomeningeal Carcinomatosis - Ross Soo (Singapore)
  • Systemic Treatment with Organ Failure - Paul Wheatley-Price (Canada)
  • HIV, Transplants - TBA

• 14:15 - 15:45

  Education Session ED 10: Controversies in Stage IIIA Disease

  Location: Colorado Convention Center, ,

  Chairs: Chandra Belani (USA), Everett Vokes (USA),

  • Staging and Decision Making in Patient Selection-Surgery - Kenji Suzuki (Japan)
  • Multiple Modality Choices: Combinations, Sequences, Subsets - Kathy Albain (USA)
  • Induction Chemotherapy as an Investigational Strategy - Wilfried Eberhardt (Germany)
  • Case Presentation - Kemp Kernstine (USA)

• 14:15 - 15:45

  Education Session ED 11: Extending Personalized Treatment Beyond EGFR

  Location: Colorado Convention Center, ,

  Chairs: Roman Perez-Soler (USA), Rolf Stahel (Switzerland),

  • What Testing is Needed for Clinical Treatment? - Paul A. Bunn, Jr (USA)
  • Communicating with Pathologists about Molecular Testing - Cesar Octavio Lara-Torres (Mexico)
  • 1st Line and Beyond for ALK, ROS-1, BRAF, RET, FGFR Positive Lung Cancer - David Spigel (USA)
  • Prioritizing New Agents when More than One is Available and Combining Targeted Agents - Ross Camidge (USA)

• 14:15 - 15:45

  Education Session ED 12: Caring for the Lung Cancer Patient

  Location: Colorado Convention Center, ,

  Chairs: Anne Frazer (New Zealand), Michelle Turner (USA),

  • Management of Paraneoplastic Syndrome - John White (United Kingdom)
  • Addressing the Nutritional Needs of the Lung Cancer Patient - Erin Williams (USA)
  • Navigating Care for the Lung Cancer Patient/The Role of the Social Worker - TBA
  • The Role of the Occupational Therapist in the Care of Lung Cancer Patients - Kahren White (USA)
  • Overcoming the Challenges of Getting Patients Through Chemo and XRT - Wilma Uyterlinde (Netherlands)
  • Importance of Exercise in Lung Cancer Treatment - Carol Michaels (USA)

• 14:15 - 15:45

  Education Session ED 13: The EGF Receptor and Targeting T790M

  Location: Colorado Convention Center, ,

  Chairs: Michael Boyer (Australia), Matthew Gubens (USA),

  • Biological Background and Controversies - Benjamin Solomon (Australia)
  • Detecting T790M in Blood and Tumor - Dara Aisner (USA)
  • How to Make the Best Use of "Old" Drugs - Geoff Oxnard (USA)
  • 3rd Generation EGFR TKI - TBA

• 14:15 - 15:45

  Pro Con PC 03a: Pro vs Con: Prophylactic Cranial Irradiation (PCI) Post Chemotherapy Response

  Location: Colorado Convention Center, ,

  Chairs: Anthony Brade (Canada), Umberto Ricardi (Italy),

  • Pro - Berend Slotman (Netherlands)
  • Con - Nobuyuki Yamamoto (Japan)

• 14:15 - 15:45

  Pro Con PC 03b: Pro vs Con: Is There a Role for Radiation in Oligometastatic Disease?

  Location: Colorado Convention Center, ,

  Chairs: Andrea Bezjak (Canada), Jin Soo Lee (South Korea),

  • Pro - Cecile Le Pechoux (France)
  • Con - Walter Curran (USA)

• 15:45 - 16:45

  Networking Break and Poster Session 3

  Location: Colorado Convention Center, Exhibit Hall,

  Chairs: , ,

  Refreshments will be provided.

• 15:45 - 16:45

  IASLC Business Meeting

  Location: Colorado Convention Center, ,

  Chairs: , ,

• 16:45 - 18:15

  Concurrent Abstract Sessions (Oral and Mini Oral)

  Location: Colorado Convention Center, various rooms,

  Chairs: , ,

ThursdaySeptember 10, 2015